Role of chaperones and FcγR in immunogenic death

Current Opinion in Immunology

Volumn 20, Issue 5, 2008, Pages 512-517

  Dhodapkar, Madhav V ^a,b   Dhodapkar, Kavita M ^b   Li, Zihai ^c  

^a YALE UNIVERSITY   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHAPERONE; FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIB; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PATTERN RECOGNITION RECEPTOR; PROTEIN P43;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; NATURAL KILLER CELL; NONHUMAN; OPSONIZATION; RECEPTOR UPREGULATION; REVIEW; ANIMAL; ANTIGEN ANTIBODY REACTION; APOPTOSIS; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; RECEPTORS, IGG;

EID: 50549099059     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.05.002     Document Type: Review

References (56)

1. Tesniere A., Panaretakis T., Kepp O., Apetoh L., Ghiringhelli F., Zitvogel L., and Kroemer G. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 15 (2008) 3-12. An excellent summary of emerging evidence for properties of immunogenic cell death.
2. Srivastava P.K. Roles of heat shock proteins in innate and adaptive immunity. Nat Rev Immunol 2 (2002) 185-194. A summary of supporting evidence for HSP to chaperone antigenic peptides, activate APC and prime T cells.
3. Binder R.J., and Srivastava P.K. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol 6 (2005) 593-599. By immunodepleting various HSPs from total cell lysates and examining the impact on subsequent T cell priming of remaining components, the critical roles of HSP in T cell priming in vivo were demonstrated.
4. Binder R.J., Vatner R., and Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64 (2004) 442-451
5. Dai J., Liu B., Caudill M.M., Zheng H., Qiao Y., Podack E.R., and Li Z. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory. Cancer Immun 3 (2003) 1
6. Oizumi S., Strbo N., Pahwa S., Deyev V., and Podack E.R. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes. J Immunol 179 (2007) 2310-2317
7. Liu B., Dai J., Zheng H., Stoilova D., Sun S., and Li Z. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci U S A 100 (2003) 15824-15829
8. Yang Y., Liu B., Dai J., Srivastava P.K., Zammit D.J., Lefrancois L., and Li Z. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 26 (2007) 215-226. By conditionally deleting gp96 gene from murine macrophages, this study demonstrated the critical roles of ER HSP gp96 in chaperoning multiple TLRs and highlighted the importance of HSP in regulating immunity by post-translational regulation of TLR expression.
9. Randow F., and Seed B. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat Cell Biol 3 (2001) 891-896
10. Liu B., Yang Y., Dai J., Medzhitov R., Freudenberg M.A., Zhang P.L., and Li Z. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol 177 (2006) 6880-6888
11. Calderwood S.K., Mambula S.S., and Gray Jr. P.J. Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 1113 (2007) 28-39
12. Li Z., Dai J., Zheng H., Liu B., and Caudill M. An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response. Front Biosci 7 (2002) d731-d751
13. Han J.M., Park S.G., Liu B., Park B.J., Kim J.Y., Jin C.H., Song Y.W., Li Z., and Kim S. Aminoacyl-tRNA synthetase-interacting multifunctional protein 1/p43 controls endoplasmic reticulum retention of heat shock protein gp96: its pathological implications in lupus-like autoimmune diseases. Am J Pathol 170 (2007) 2042-2054
14. Eustace B.K., Sakurai T., Stewart J.K., Yimlamai D., Unger C., Zehetmeier C., Lain B., Torella C., Henning S.W., Beste G., et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6 (2004) 507-514
15. Gehrmann M., Liebisch G., Schmitz G., Anderson R., Steinem C., De Maio A., Pockley G., and Multhoff G. Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS ONE 3 (2008) e1925
16. Casares N., Pequignot M.O., Tesniere A., Ghiringhelli F., Roux S., Chaput N., Schmitt E., Hamai A., Hervas-Stubbs S., Obeid M., et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202 (2005) 1691-1701
17. Blachere N.E., Darnell R.B., and Albert M.L. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 3 (2005) e185
18. Obeid M., Tesniere A., Ghiringhelli F., Fimia G.M., Apetoh L., Perfettini J.L., Castedo M., Mignot G., Panaretakis T., Casares N., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13 (2007) 54-61. This pioneering work demonstrated that anthracyclines induce preapoptotic translocation of CRT to the cell surface, and subsequent DC activation and tumor immunity via CRT.
19. ••,21] together suggest a role for exposure of HSPs on dying cells as a marker for immunogenicity of tumors.
20. Gamrekelashvili J., Kruger C., von Wasielewski R., Hoffmann M., Huster K.M., Busch D.H., Manns M.P., Korangy F., and Greten T.F. Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol 178 (2007) 1573-1580
21. Obeid M., Panaretakis T., Joza N., Tufi R., Tesniere A., van Endert P., Zitvogel L., and Kroemer G. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ 14 (2007) 1848-1850
22. Spisek R., and Dhodapkar M.V. Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells. Cell Cycle 6 (2007) 1962-1965
23. Elsner L., Muppala V., Gehrmann M., Lozano J., Malzahn D., Bickeboller H., Brunner E., Zientkowska M., Herrmann T., Walter L., et al. The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands. J Immunol 179 (2007) 5523-5533
24. Seong S.Y., and Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4 (2004) 469-478. This essay argues compellingly that PAMPs and tissue-derived danger signals are not mutually exclusive, but rather share similar biochemical features in the form of exposed hydrophobicity or DAMPs which initiate immunity.
25. Tsan M.F., and Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 76 (2004) 514-519
26. Menoret A., Patry Y., Burg C., and Le Pendu J. Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas. J Immunol 155 (1995) 740-747
27. Melcher A., Todryk S., Hardwick N., Ford M., Jacobson M., and Vile R.G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 4 (1998) 581-587
28. Nimmerjahn F., and Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8 (2008) 34-47. An excellent review of the role of Fcγ receptors as regulators of immune responses.
29. Hamerman J.A., and Lanier L.L. Inhibition of immune responses by ITAM-bearing receptors. Sci STKE 2006 (2006) re1
30. Dhodapkar M.V., Dhodapkar K.M., and Palucka A.K. Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ 15 (2008) 39-50
31. Erwig L.P., McPhilips K.A., Wynes M.W., Ivetic A., Ridley A.J., and Henson P.M. Differential regulation of phagosome maturation in macrophages and dendritic cells mediated by Rho GTPases and ezrin-radixin-moesin (ERM) proteins. Proc Natl Acad Sci U S A 103 (2006) 12825-12830
32. Bergtold A., Desai D.D., Gavhane A., and Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23 (2005) 503-514
33. Delamarre L., Couture R., Mellman I., and Trombetta E.S. Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J Exp Med 203 (2006) 2049-2055
34. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Thery C., Rescigno M., Saito T., Verbeek S., Bonnerot C., Ricciardi-Castagnoli P., et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189 (1999) 371-380
35. Dhodapkar K.M., Krasovsky J., Williamson B., and Dhodapkar M.V. Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J Exp Med 195 (2002) 125-133
36. Groh V., Li Y.Q., Cioca D., Hunder N.N., Wang W., Riddell S.R., Yee C., and Spies T. Efficient cross-priming of tumor antigen specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells. Proc Natl Acad Sci U S A 102 (2005) 6461-6466
37. Dhodapkar K.M., and Dhodapkar M.V. Recruiting dendritic cells to improve antibody therapy of cancer. Proc Natl Acad Sci U S A 102 (2005) 6243-6244
38. Woelbing F., Kostka S.L., Moelle K., Belkaid Y., Sunderkoetter C., Verbeek S., Waisman A., Nigg A.P., Knop J., Udey M.C., et al. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med 203 (2006) 177-188
39. Dhodapkar K.M., Banerjee D., Connolly J., Kukreja A., Matayeva E., Veri M.C., Ravetch J.V., Steinman R.M., and Dhodapkar M.V. Selective blockade of the inhibitory Fc{gamma} receptor (Fc{gamma}RIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med 204 (2007) 1359-1369
40. Dhodapkar K.M., Kaufman J.L., Ehlers M., Banerjee D.K., Bonvini E., Koenig S., Steinman R.M., Ravetch J.V., and Dhodapkar M.V. Selective blockade of inhibitory Fc gamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci U S A 102 (2005) 2910-2915
41. ••] demonstrate the importance of the balance between activating and inhibitory Fc receptors in regulating dendritic cell activation.
42. Schuurhuis D.H., van Montfoort N., Ioan-Facsinay A., Jiawan R., Camps M., Nouta J., Melief C.J., Verbeek J.S., and Ossendorp F. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol 176 (2006) 4573-4580
43. Banerjee D., Matthews P., Matayeva E., Kaufman J.L., Steinman R., and Dhodapkar K. Enhanced T cell responses to glioma cells coated with anti-EGF receptor antibody and targeted to activating FcgRs on human dendritic cells. J Immunotherapy 31 (2008) 113-120
44. Liu Y., Gao X., Masuda E., Redecha P.B., Blank M.C., and Pricop L. Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. J Immunol 177 (2006) 8440-8447
45. Kalergis A.M., and Ravetch J.V. Inducing tumor immunity through the selective engagement of activating Fc receptors on dendritic cells. J Exp Med 195 (2002) 1653-1659
46. Rafiq K., Bergtold A., and Clynes R. Immune complex-mediated antigen presentation induces tumor immunity. J Clin Invest 110 (2002) 71-79
47. Clynes R., Dumitru C., and Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 (1998) 1052-1054
48. Desai D.D., Harbers S.O., Flores M., Colonna L., Downie M.P., Bergtold A., Jung S., and Clynes R. Fc{gamma} Receptor IIB on Dendritic Cells Enforces Peripheral Tolerance by Inhibiting Effector T Cell Responses. J Immunol 178 (2007) 6217-6226
49. ••] demonstrate the critical role for inhibitory FcRs in maintaining peripheral tolerance to self antigens.
50. Sedlik C., Orbach D., Veron P., Schweighoffer E., Colucci F., Gamberale R., Ioan-Facsinay A., Verbeek S., Ricciardi-Castagnoli P., Bonnerot C., et al. A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation. J Immunol 170 (2003) 846-852
51. Herrada A.A., Contreras F.J., Tobar J.A., Pacheco R., and Kalergis A.M. Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells. Proc Natl Acad Sci U S A 104 (2007) 13402-13407
52. Laborde E.A., Vanzulli S., Beigier-Bompadre M., Isturiz M.A., Ruggiero R.A., Fourcade M.G., Catalan Pellet A.C., Sozzani S., and Vulcano M. Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 179 (2007) 673-681
53. Clatworthy M.R., Willcocks L., Urban B., Langhorne J., Williams T.N., Peshu N., Watkins N.A., Floto R.A., and Smith K.G. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci U S A 104 (2007) 7169-7174
54. van Montfoort N., de Jong J.M., Schuurhuis D.H., van der Voort E.I., Camps M.G., Huizinga T.W., van Kooten C., Daha M.R., Verbeek J.S., Ossendorp F., et al. A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes. J Immunol 178 (2007) 7581-7586
55. Thomas-Rudolph D., Du Clos T.W., Snapper C.M., and Mold C. C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc gamma R on dendritic cells. J Immunol 178 (2007) 7283-7291
56. Adams G.P., and Weiner L.M. Monoclonal antibody therapy of cancer. Nat Biotechnol 23 (2005) 1147-1157